APR 25, 2021 10:21 AM PDT

Natural Molecules Can Stop Antibodies From Neutralizing SARS-CoV-2

WRITTEN BY: Carmen Leitch

When we're exposed to a pathogen, our immune system normally mounts a robust response against it. Antibodies are generated to bind to the pathogen. Antibodies that neutralize a virus can stop it from infecting more cells and causing more illness. However, some people that have COVID-19 carry high levels of antibodies against the SARS-CoV-2 virus, but they still get really sick. Now researchers may have an explanation. Their work has identified natural molecules that are present in the human body called biliverdin and bilirubin that seem to prevent antibodies from binding to the SARS-CoV-2 virus. The findings have been reported in Science Advances.

  Transmission electron micrograph of a SARS-CoV-2 virus particle (UK B.1.1.7 variant), isolated from a patient sample and cultivated in cell culture. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. / Credit: NIAID

These molecules seem to interfere with antibodies that bind to the spike protein of the coronavirus, which is what the pathogen uses to get into cells and infect them, which ultimately generates and releases more viral particles. Biliverdin and bilirubin may be present at variable levels in different people, and are generated normally as red blood cells break down.

While the world is extremely lucky to have gotten vaccines on the timetable we did, which few expected, it was largely due to behind-the-scenes work on mRNA vaccines that a handful of people were quietly toiling at for many years. The elusive nature of a decent treatment for COVID-19 shows how long it can take to learn what we need to know about a pathogen in order to fight it. Researchers will certainly be continuing to learn more about how immunity against SARS-CoV-2 can be built and maintained.

Francis Crick Institute researchers found that the spike protein of SARS-CoV-2 can strongly bind to biliverdin. Collaborating with other teams revealed that the interaction between the spike protein and biliverdin was reducing the ability of antibodies to bind to the spike protein. Using samples that had been donated by people once infected with SARS-CoV-2, the researchers determined that biliverdin could suppress the binding between antibodies and spike protein by 30 to 50 percent. Some antibodies became totally ineffective at neutralizing the virus.

"When SARS-CoV-2 infects a patient's lungs it damages blood vessels and causes a rise in the number [of] immune cells. Both of these effects may contribute to increasing the levels of biliverdin and bilirubin in the surrounding tissues. And with more of these molecules available, the virus has more opportunity to hide from certain antibodies," said first study author Annachiara Rosa Ph.D., a postdoctoral training fellow in the Chromatin structure and mobile DNA Laboratory at the Crick. "This is a really striking process, as the virus may be benefiting from a side-effect of the damage it has already caused."

Sources: AAAS/Eurekalert! via The Crick Institute, Science Advances

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
APR 21, 2021
Microbiology
An Unknown Unknown - What's the State of Microbial Biodiversity?
APR 21, 2021
An Unknown Unknown - What's the State of Microbial Biodiversity?
Researchers have noted that we have a 'profound ignorance' about the state of the microbial populations of the world.
APR 28, 2021
Plants & Animals
Insight Into the Evolution of Madagascar's 'Horned' Crocodile
APR 28, 2021
Insight Into the Evolution of Madagascar's 'Horned' Crocodile
Madagascar is home to many unusual animals. A skull from one - the 'horned' crocodile - can be seen in this image by M. ...
MAY 11, 2021
Genetics & Genomics
Gene Therapy Trial for Severe Immune Disorder is Successful
MAY 11, 2021
Gene Therapy Trial for Severe Immune Disorder is Successful
Severe combined immunodeficiency (SCID), which virtually eliminates a patient's immune system, and severely affects thei ...
MAY 12, 2021
Cardiology
Reversing the Heart Damage Seen in Marfan Syndrome
MAY 12, 2021
Reversing the Heart Damage Seen in Marfan Syndrome
Marfan syndrome is a genetic disorder that disrupts the connective tissues that anchor and link the body's organs, affec ...
MAY 23, 2021
Microbiology
Move Over Bacteria, Make Way for Protists
MAY 23, 2021
Move Over Bacteria, Make Way for Protists
In the world of microbes, organisms like viruses and bacteria get a lot of attention. But researchers are beginning to s ...
MAY 28, 2021
Genetics & Genomics
Some Biofilms Seem to Activate Cancer Genes
MAY 28, 2021
Some Biofilms Seem to Activate Cancer Genes
New research assessed bacterial and fungal biofilms, tenacious microbial communities that are tougher than small groups ...
Loading Comments...